Imvaria
About Imvaria
Imvaria is a healthcare AI company that specializes in pioneering AI-driven digital biomarker solutions to enhance clinical decision-making, particularly in the early and accurate diagnosis and prognosis of serious diseases. Founded by physician-engineers from Stanford and Google, the company leverages automated machine-learning algorithm technology to generate physiologic signatures from clinical testing and imaging data, transforming complex clinical assessments into data science.
For physicians, Imvaria offers FDA-authorized AI diagnostic tools such as Fibresolve and ScreenDx, which are designed to assist in the non-invasive diagnosis and assessment of lung conditions, including Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF). Fibresolve, for instance, is the first FDA-authorized AI adjunctive diagnostic service in lung fibrosis, providing diagnostic subtype classification in suspected ILD and IPF by analyzing lung CT imaging. ScreenDx, FDA-cleared in 2025, automatically assesses CT imaging for interstitial lung findings to flag cases for referral workflows, aiming to reduce diagnostic delays. Additionally, Imvaria is developing Bronchosolve, an investigational AI tool for more accurate malignancy assessment in suspicious pulmonary nodules and lung cancer diagnosis, which has met primary endpoints in pivotal studies. These solutions are delivered through a centralized AI Lab diagnostic service, integrating seamlessly into clinical workflows to provide new insights and support optimal patient outcomes without requiring complex changes to existing practices.
What Physicians Need to Know
Imvaria stands out for physicians by directly addressing key pain points: reducing burnout through automation, improving diagnostic confidence with explainable AI, and enhancing patient outcomes via personalized, predictive insights. Our tools are designed to be intuitive, integrate seamlessly into existing clinical workflows, and provide actionable intelligence rather than just data, ultimately giving physicians more time and better information to care for their patients. The focus on transparency (XAI) builds trust, ensuring physicians understand and can validate the AI's recommendations, empowering them to make the final, informed clinical decisions.
Imvaria prioritizes robust interoperability, offering out-of-the-box integrations with leading EHR systems (e.g., Epic, Cerner, Meditech) via FHIR APIs and other standard protocols. We also provide custom integration capabilities to accommodate unique IT environments and specialized clinical systems, ensuring a smooth and efficient deployment process with minimal disruption to current operations.
Reviews & Opinions
Videos
News, demos, and interviews about Imvaria.
Videos load interactively. If none appear, search YouTube for Imvaria →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Imvaria.
Comparisons
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]